Mahatme Ujwala 4
4 · Summit Therapeutics Inc. · Filed Feb 23, 2021
Insider Transaction Report
Form 4
Mahatme Ujwala
Director
Transactions
- Award
Stock Option (right to buy)
2021-02-19+25,000→ 238,340 totalExercise: $7.33From: 2021-12-31Exp: 2031-02-19→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The option was granted on February 19, 2021. The shares underlying the option are scheduled to vest in full on December 31, 2021.
- [F2]Not applicable.